Among these, triterpenoids, such as Lupeol, cycloartenol, and β-sitosterol, are of special interest due to their established ability to interfere with tumor progression through modulation of the NF-κB, PI3K/Akt, and MAPK pathways [10,11]. Here, AKT1 is linked to neoplasm.